Close Menu

NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Thursday that its first quarter revenues rose 3 percent year over year, thanks largely to an 8 percent revenue growth in its diagnostics business.

For the three months ended April 2, the company reported revenues of $514.1 million, up from $498.0 million a year earlier, and beating the average Wall Street analyst estimate of $506.8 million. Organic revenues increased 4 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A genetic genealogy analysis helped secure the release of a California man from prison after getting his murder conviction overturned, the Guardian reports.

Technology Review discusses the concerns that come along with the ability to quickly synthesize viruses like SARS-CoV-2.

Researchers have uncovered large bacteriophages whose genomes include translational machinery, Live Science reports.

In PNAS this week: role for Myc in alternative splicing regulation in prostate cancer, variation in methylation in Arabidopsis, and more.